Literature DB >> 16515807

Can adjustment disorder and depressive episode be distinguished? Results from ODIN.

Patricia Casey1, Mohammad Maracy, Brendan D Kelly, Ville Lehtinen, Jose-Luis Ayuso-Mateos, Odd S Dalgard, Christopher Dowrick.   

Abstract

BACKGROUND: No large-scale epidemiological study has included adjustment disorders (AD) for consideration yet it is considered to be a common psychiatric diagnosis.
METHODS: Using a two stage screening method, those above a threshold score for possible caseness on the Beck Depression Inventory (BDI), were interviewed using SCAN to identify those with depressive episode and AD. Variables that might distinguish AD from depressive episode were examined.
RESULTS: The prevalence of AD was extremely low with one centre having no cases. Finland, the country with the highest prevalence, only achieved a frequency of 0.8% and 1%, respectively, for urban and rural sites. Logistic regression failed to identify any variables that independently differentiated AD from depressive episode. Findings relating to severity of symptoms using BDI were robust. LIMITATIONS: The small sample size might have contributed to a failure to identify distinguishing features between AD and other disorders.
CONCLUSIONS: Reasons for the failure of even robust results, such as BDI severity, to distinguish AD from depressive episode are considered of which problems in conceptualising AD are the most likely. Further studies are required.

Entities:  

Mesh:

Year:  2006        PMID: 16515807     DOI: 10.1016/j.jad.2006.01.021

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

1.  Adjustment disorders: prevalence in a representative nationwide survey in Germany.

Authors:  Andreas Maercker; Simon Forstmeier; Laura Pielmaier; Lena Spangenberg; Elmar Brähler; Heide Glaesmer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-03-11       Impact factor: 4.328

2.  Adjustment disorders: the state of the art.

Authors:  Patricia Casey; Susan Bailey
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

3.  Development and validation of the Diagnostic Interview Adjustment Disorder (DIAD).

Authors:  L R Cornelius; S Brouwer; M R de Boer; J W Groothoff; J J L van der Klink
Journal:  Int J Methods Psychiatr Res       Date:  2014-01-30       Impact factor: 4.035

Review 4.  Adjustment disorder: new developments.

Authors:  Patricia Casey
Journal:  Curr Psychiatry Rep       Date:  2014-06       Impact factor: 5.285

Review 5.  Adjustment disorder: epidemiology, diagnosis and treatment.

Authors:  Patricia Casey
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

6.  The development of valid subtypes for depression in primary care settings: a preliminary study using an explanatory model approach.

Authors:  Alison Karasz
Journal:  J Nerv Ment Dis       Date:  2008-04       Impact factor: 2.254

7.  Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Sarah L Minden; Anthony Feinstein; Rosalind C Kalb; Deborah Miller; David C Mohr; Scott B Patten; Christopher Bever; Randolph B Schiffer; Gary S Gronseth; Pushpa Narayanaswami
Journal:  Neurology       Date:  2013-12-27       Impact factor: 9.910

8.  Depressive and adjustment disorders - some questions about the differential diagnosis: case studies.

Authors:  A Presicci; P Lecce; P Ventura; F Margari; S Tafuri; L Margari
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

9.  Adjustment Disorder: epidemiology, diagnosis and treatment.

Authors:  Mauro Giovanni Carta; Matteo Balestrieri; Andrea Murru; Maria Carolina Hardoy
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-06-26

10.  Major depression epidemiology from a diathesis-stress conceptualization.

Authors:  Scott B Patten
Journal:  BMC Psychiatry       Date:  2013-01-11       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.